Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01769209
Title Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University

acute lymphoblastic leukemia



Cytarabine + Methotrexate

Dexamethasone + Doxorubicin + Pegaspargase + Vincristine Sulfate

Age Groups: adult
Covered Countries USA

No variant requirements are available.